Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Free Cash Flow (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Free Cash Flow for 2 consecutive years, with -$13.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Free Cash Flow rose 9.46% to -$13.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$72.4 million, a N/A change, with the full-year FY2024 number at -$57.9 million, up 25.22% from a year prior.
  • Free Cash Flow was -$13.3 million for Q3 2025 at Pyxis Oncology, up from -$17.3 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$3.0 million in Q2 2024 to a low of -$22.5 million in Q1 2025.